News Image

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Provided By GlobeNewswire

Last update: Apr 9, 2025

Successful robotic navigation was achieved in every case and met the primary endpoint of the study

LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported

Read more at globenewswire.com

MICROBOT MEDICAL INC

NASDAQ:MBOT (6/18/2025, 9:47:16 AM)

2.4578

+0.04 (+1.56%)



Find more stocks in the Stock Screener

Follow ChartMill for more